Interval Between Different Vaccines: Clinical Considerations and Public Health Recommendations
Interim clinical considerations provide guidance on the interval between different vaccines for optimal immunization coverage and public health impact, supporting evidence-based decision-making and vaccine administration strategies.
Februery 2022
Risks and Benefits of Myopia Control: Insights from Clinical Studies
Potential benefits of myopia control outweigh the risks, as evidenced by findings from clinical studies, highlighting the importance of early intervention and personalized management approaches to mitigate the progression of myopia and associated complications.
Februery 2022
Excessive Use of Diagnostic Tests: Challenges and Clinical Implications
Excessive use of diagnostic tests is prevalent across various clinical scenarios, highlighting the need for judicious test utilization, evidence-based guidelines, and clinician education to optimize diagnostic accuracy and patient care.
Februery 2022
The Flu Vaccine in the COVID-19 Era: Reductions in ICU Admissions, Sepsis, and Strokes
Largest study of its kind suggests that the flu vaccine reduces ICU admissions, sepsis, and strokes, highlighting the potential benefits of influenza vaccination in reducing the burden on healthcare systems and improving patient outcomes during the COVID-19 pandemic.
Februery 2022
Low-Risk Prostate Cancer: Insights from Studies on Active Surveillance
Two new studies provide insights into the management of low-risk prostate cancer through active surveillance, offering evidence-based recommendations and highlighting the importance of personalized treatment approaches to minimize overtreatment and preserve quality of life in affected individuals.
Februery 2022
Takeaways from the 2021 Annual Meeting of Latin American Dermatologists (RADLA)
Featured messages highlight key insights and research advancements presented at the 2021 Annual Meeting of Latin American Dermatologists (RADLA), covering a wide range of topics in dermatology and clinical practice.
Februery 2022
Unruptured Intracranial Aneurysms: Clinical Characteristics and Management Considerations
Unruptured intracranial aneurysms are usually asymptomatic and incidentally discovered on neuroimaging, prompting considerations for surveillance and treatment strategies to mitigate the risk of rupture and prevent adverse neurological outcomes.
Februery 2022
Hypertonic Saline Solution in Traumatic Brain Injury: Lack of Neurological Improvement
Hypertonic saline solution does not lead to neurological improvement at 6 months in patients with traumatic brain injury, highlighting the need for alternative therapeutic approaches and personalized management strategies in severe TBI cases.
Februery 2022
Effectiveness of Pfizer-BioNTech and Oxford/AstraZeneca Vaccines: Insights from Real-World Data
Large observational study from the United Kingdom demonstrates >60% protection against symptomatic COVID-19 with Pfizer-BioNTech and Oxford/AstraZeneca vaccines 28 days after one dose, supporting the effectiveness of COVID-19 vaccination in reducing disease transmission and severity.
Februery 2022
